GB Sciences Inc (GBLX)

OTC Markets
0.0210
+0.0005(+2.44%)
  • Volume:
    174,457
  • Bid/Ask:
    0.0000/0.0000
  • Day's Range:
    0.0200 - 0.0210

GBLX Overview

Prev. Close
0.0205
Day's Range
0.02-0.021
Revenue
-
Open
0.0205
52 wk Range
0.0175-0.0598
EPS
-0.002
Volume
174,457
Market Cap
6.91M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
137,706
P/E Ratio
-43.38
Beta
0.134
1-Year Change
-62.41%
Shares Outstanding
329,204,224
Next Earnings Date
-
What is your sentiment on GB Sciences?
or
Vote to see community's results!

GB Sciences Inc News

GB Sciences Inc Company Profile

GB Sciences Inc Company Profile

Employees
23

GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson’s disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyNeutralSellStrong Sell
Technical IndicatorsBuyBuyNeutralStrong SellStrong Sell
SummaryBuyBuyNeutralStrong SellStrong Sell
  • This is going to be the stock that booms in the near future.
    0
    • Why can’t you just break out only at 94.55 percent
      0